Juvenile systemic scleroderma.

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Systemic scleroderma in children is very rare and is considered similar to adult-onset disease. In adults, new etiopathogenetic and therapeutic approaches have emerged in recent years. For instance, it has been shown that microchimerism could play a role in disease pathogenesis and that immunoablation followed by stem cell rescue could be of potential therapeutic benefit. There is also evidence that these new approaches can be of value for childhood-onset disease.

Original languageEnglish
Pages (from-to)387-390
Number of pages4
JournalCurrent Rheumatology Reports
Volume3
Issue number5
Publication statusPublished - Oct 2001

Fingerprint

Chimerism
Systemic Scleroderma
Stem Cells
Therapeutics
Juvenile systemic scleroderma

ASJC Scopus subject areas

  • Rheumatology

Cite this

Juvenile systemic scleroderma. / Martini, A.

In: Current Rheumatology Reports, Vol. 3, No. 5, 10.2001, p. 387-390.

Research output: Contribution to journalArticle

@article{e4ed996b6b964f1985857586a75cb788,
title = "Juvenile systemic scleroderma.",
abstract = "Systemic scleroderma in children is very rare and is considered similar to adult-onset disease. In adults, new etiopathogenetic and therapeutic approaches have emerged in recent years. For instance, it has been shown that microchimerism could play a role in disease pathogenesis and that immunoablation followed by stem cell rescue could be of potential therapeutic benefit. There is also evidence that these new approaches can be of value for childhood-onset disease.",
author = "A. Martini",
year = "2001",
month = "10",
language = "English",
volume = "3",
pages = "387--390",
journal = "Current Rheumatology Reports",
issn = "1523-3774",
publisher = "Current Science, Inc.",
number = "5",

}

TY - JOUR

T1 - Juvenile systemic scleroderma.

AU - Martini, A.

PY - 2001/10

Y1 - 2001/10

N2 - Systemic scleroderma in children is very rare and is considered similar to adult-onset disease. In adults, new etiopathogenetic and therapeutic approaches have emerged in recent years. For instance, it has been shown that microchimerism could play a role in disease pathogenesis and that immunoablation followed by stem cell rescue could be of potential therapeutic benefit. There is also evidence that these new approaches can be of value for childhood-onset disease.

AB - Systemic scleroderma in children is very rare and is considered similar to adult-onset disease. In adults, new etiopathogenetic and therapeutic approaches have emerged in recent years. For instance, it has been shown that microchimerism could play a role in disease pathogenesis and that immunoablation followed by stem cell rescue could be of potential therapeutic benefit. There is also evidence that these new approaches can be of value for childhood-onset disease.

UR - http://www.scopus.com/inward/record.url?scp=0035486712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035486712&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 387

EP - 390

JO - Current Rheumatology Reports

JF - Current Rheumatology Reports

SN - 1523-3774

IS - 5

ER -